EFPIA Newsletter 24 October 2024

Overcoming the barriers to Europe’s leadership in medical innovation     Read more   Over the years, Europe’s share of global medicine R&D investments has dropped. However, with the new EU mandate, there is a chance to turn this around. At the start of the EU’s new mandate, we have the chance to reset the agenda for life sciences.  An op-ed by Lars Fruergaard Jørgensen, CEO, Novo Nordisk; EFPIA President, Stefan Oelrich, member of the board of management, Bayer; EFPIA Vice President and David Loew, CEO, Ipsen; EFPIA Second Vice President.   Read more →

60,000 fewer clinical trial places for Europeans, despite global surge in research projects Despite global clinical trials increasing by 38% over the past decade, the European Economic Area’s (EEA) global share of trials has halved over the same period. A new report by IQVIA for EFPIA and Vaccines Europe, shows that the EEA’s share of commercial trials – those sponsored by a pharmaceutical company – has reduced from 22% in 2013, to 18% in 2018 to 12% in 2023. Read the full report here.

Blogs     24 October 2024 Let’s dig deeper on Unmet Medical Need Stefan Frings explains why a broad, encompassing definition of Unmet Medical Need, is key in R&D investment decisions.... Read more →

Events     05 NOV 2024   FT Global Pharma & Biotech Summit 2024 Hybrid event - London, UK Leading executives from over 250 life sciences, pharmaceutical and biotechnology industries will gather in London at... Learn more →       12 NOV 2024   Innovating for Impact: Shaping the Future of Rare Disease Treatment Virtual event This Euronews debate will look deeper into what needs to be done at the research and policy level. Learn more →

	13 NOV 2024			Advancing the precision oncology agenda in the EU Brussels, Belgium As the European Union enters a new mandate, with fresh leadership defining future legislative and policy directions,... Learn more →

	10 DEC 2024			IMAGINE a healthier, more competitive Europe Brussels & Online Register now to reserve your seat. Learn more →

What we are reading Whatever happened to Europe’s support for IP protection, Draghi report asks 22 October 2024  (IP Europe) Read more → Europe falls behind China in playing host to clinical drug trials 22 October 2024  (Financial Times) Read more → ERDERA Pre-Announces 2025 Joint Transnational Call for Proposals on Rare Disease Therapies 16 October 2024  (ERDERA) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe